X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES DISHMAN PHARMA JUBILANT LIFE SCIENCES/
DISHMAN PHARMA
 
P/E (TTM) x 16.7 25.1 66.5% View Chart
P/BV x 4.4 3.3 131.1% View Chart
Dividend Yield % 0.4 0.7 62.4%  

Financials

 JUBILANT LIFE SCIENCES   DISHMAN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
DISHMAN PHARMA
Mar-16
JUBILANT LIFE SCIENCES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs187374 49.9%   
Low Rs65129 50.5%   
Sales per share (Unadj.) Rs364.3197.8 184.2%  
Earnings per share (Unadj.) Rs6.821.2 32.3%  
Cash flow per share (Unadj.) Rs24.534.7 70.6%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %2.40.8 299.7%  
Book value per share (Unadj.) Rs164.9179.9 91.7%  
Shares outstanding (eoy) m159.2880.69 197.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 27.2%   
Avg P/E ratio x18.411.9 155.0%  
P/CF ratio (eoy) x5.17.2 70.9%  
Price / Book Value ratio x0.81.4 54.6%  
Dividend payout %43.89.4 464.6%   
Avg Mkt Cap Rs m20,06120,306 98.8%   
No. of employees `0006.20.8 746.1%   
Total wages/salary Rs m11,0525,355 206.4%   
Avg. sales/employee Rs Th9,383.019,252.7 48.7%   
Avg. wages/employee Rs Th1,786.96,459.5 27.7%   
Avg. net profit/employee Rs Th176.32,064.1 8.5%   
INCOME DATA
Net Sales Rs m58,03415,961 363.6%  
Other income Rs m191265 71.8%   
Total revenues Rs m58,22416,226 358.8%   
Gross profit Rs m5,7864,103 141.0%  
Depreciation Rs m2,8121,091 257.8%   
Interest Rs m3,237944 342.8%   
Profit before tax Rs m-722,334 -3.1%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696624 111.7%   
Profit after tax Rs m1,0901,711 63.7%  
Gross profit margin %10.025.7 38.8%  
Effective tax rate %-965.926.7 -3,614.5%   
Net profit margin %1.910.7 17.5%  
BALANCE SHEET DATA
Current assets Rs m29,28011,018 265.8%   
Current liabilities Rs m38,9129,517 408.9%   
Net working cap to sales %-16.69.4 -176.5%  
Current ratio x0.81.2 65.0%  
Inventory Days Days84110 76.4%  
Debtors Days Days5135 145.5%  
Net fixed assets Rs m55,71216,304 341.7%   
Share capital Rs m155161 95.7%   
"Free" reserves Rs m20,96812,907 162.5%   
Net worth Rs m26,26514,516 180.9%   
Long term debt Rs m17,1694,189 409.8%   
Total assets Rs m88,60629,805 297.3%  
Interest coverage x1.03.5 28.2%   
Debt to equity ratio x0.70.3 226.5%  
Sales to assets ratio x0.70.5 122.3%   
Return on assets %4.98.9 54.8%  
Return on equity %4.211.8 35.2%  
Return on capital %11.617.5 66.0%  
Exports to sales %37.824.8 152.5%   
Imports to sales %16.53.7 441.3%   
Exports (fob) Rs m21,9333,956 554.4%   
Imports (cif) Rs m9,567596 1,604.4%   
Fx inflow Rs m22,0044,952 444.4%   
Fx outflow Rs m11,749697 1,686.1%   
Net fx Rs m10,2554,255 241.0%   
CASH FLOW
From Operations Rs m8,0262,786 288.0%  
From Investments Rs m-1,744-1,529 114.1%  
From Financial Activity Rs m-4,447-941 472.6%  
Net Cashflow Rs m1,834316 579.8%  

Share Holding

Indian Promoters % 45.6 61.4 74.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.7 235.1%  
FIIs % 21.2 12.7 166.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 22.1 95.5%  
Shareholders   23,815 46,261 51.5%  
Pledged promoter(s) holding % 15.9 35.8 44.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Metal & Realty Stocks Drag(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.1% while the Hang Seng is down 0.5%.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 16, 2018 11:53 AM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS